08:30 | Emory Chemical Biology Discovery Centre | |
09:00 | Medicinal Chemistry Capabilities in Academic Drug Discovery: You have a hit…what's next? | |
09:30 | The Sloan-Kettering Discovery Engine & Approach | |
10:00 | High Throughput Flow Cytometry at the University of New Mexico Center for Molecular Discovery: Cellular and Molecular Targets in Multiplexed and Multiparameter Format | |
10:30 | Coffee Break and Networking | |
11:15 | Seven years of HTS/HCS at the University of Pittsburgh - it’s the Collaborations Baby | |
12:15 | EU-OPENSCREEN, Chemical Keys for Life's Locks | |
12:45 | BARD: BioAssay Research Database | |
13:20 | Lunch, Poster Viewing and Networking | |
14:30 | Expert Panel discussion on “Trends on enabling technologies & the future of academic screening” | |
18:00 | Drinks Reception |
08:00 | Open Innovation-based Public-Private Partnerships: Promise or Panacea for Precompetitive Drug Discovery Initiatives | |
08:30 | Academic-Industry Partnerships, the Challenges of Advancing and Managing Innovation | |
09:00 | An Industrial Perspective of HTS in Academia | |
09:30 | Integrating Target Validation, Drug Discovery and Chemical Biology | |
10:00 | The Conrad Prebys Center for Chemical Genomics for Internal and Collaborative Pre-clinical Drug Discovery with Pharma Co/Biotech Partners – Lessons Learned and Best Practices | |
10:30 | Coffee Break and Networking | |
11:15 | Pre-Competitive Collaboration at the Structural Genomics Consortium | |
11:45 | Promega’s New Outreach Program to Support Design of Assays Submitted to Academic Screening Centers | |
12:15 | GVK BIO as an Academic Partner - Value-added, High Quality, Cost-effective Enabler of Drug Discovery & Development | |
12:45 | Lunch, Poster Viewing and Networking | |
14:30 | Expert panel discussion on “Should academia be doing drug discovery?” | |
17:00 | Workshop Ends |